Research programme: vaccines - Panacea Biotec

Drug Profile

Research programme: vaccines - Panacea Biotec

Alternative Names: 13-Valent pneumococcal vaccine - Panacea Biotec; 15-Valent pneumococcal vaccine - Panacea Biotec; Dengue vaccine - Panacea Biotec; DTaP - Panacea Biotec; DTaP-HIB-TT-HepB-IPV - Panacea Biotec; DTaP-HIB-TT-IPV - Panacea Biotec; Hapy3; Hapyfive; Hapysix; Inactivated JEV vaccine - Panacea Biotec; Influenza virus vaccine universal - Panacea Biotec; Japanese encephalitis vaccine - Panacea Biotec; Live-attenuated dengue vaccine - Panacea Biotec; Measles vaccine - Panacea Biotec; Meninogococcal vaccine - Panacea Biotec; Neisseria meningitidis vaccine tetravalent - Panacea Biotec; Pneumococcal conjugate CRM vaccine; rDen-delta-30 NIH vaccine - Panacea Biotec; Recombinant influenza virus vaccine universal - Panacea Biotec; Recombinant tetravalent dengue vaccine - Panacea Biotec; Tetravalent meningococcal vaccine - Panacea Biotec; Universal influenza virus vaccine - Panacea Biotec

Latest Information Update: 28 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Panacea Biotec; PT Bio Farma
  • Developer National Institute of Immunology; Panacea Biotec
  • Class Bacterial vaccines; Synthetic vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Pneumococcal infections

Highest Development Phases

  • No development reported Dengue; Influenza virus infections; Japanese encephalitis; Measles; Meningococcal infections; Pneumococcal infections

Most Recent Events

  • 28 Feb 2018 No recent reports of development identified for preclinical development in Dengue in India (IM, Injection)
  • 28 Feb 2018 No recent reports of development identified for preclinical development in Influenza-virus-infections in India (IM, Injection)
  • 28 Feb 2018 No recent reports of development identified for preclinical development in Japanese encephalitis in India (IM, Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top